Barrot H Lambdin
Overview
Explore the profile of Barrot H Lambdin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Philbrick S, Smith J, Wenger L, Akiba C, Hairgrove S, Tookes H, et al.
J Subst Use Addict Treat
. 2025 Mar;
172:209670.
PMID: 40054698
Background: Access to medications for opioid use disorder (MOUD) is essential for the 6.1 million Americans with OUD. However, only one in five adults with past-year OUD received MOUD. Syringe...
2.
Good D, Shin S, Kappesser K, Leichtling G, Godvin M, Wenger L, et al.
Int J Drug Policy
. 2025 Feb;
138:104745.
PMID: 40014932
Background: In November 2020, Oregon voters passed Ballot Measure 110 (M110), which decriminalized personal possession of controlled substances and dramatically increased funding for lowering barriers to accessing substance use treatment...
3.
Bazzi A, Roth A, Akiba C, Huffaker S, Patel S, Smith J, et al.
PLoS One
. 2025 Feb;
20(2):e0319340.
PMID: 39999129
With changing drug supplies and associated drug consumption behaviors, HIV transmission has increased among people who inject drugs in the United States. HIV testing and referrals to effective prevention and...
4.
Chung E, Wenger L, Good D, Leichtling G, Godvin M, Lambdin B, et al.
BMC Public Health
. 2025 Feb;
25(1):740.
PMID: 39988688
Background: Unstable housing has tremendous harms on health and well-being and people who use drug experience significant barriers to housing. The objectives of this study were to estimate the prevalence...
5.
Chung E, Patel S, Wenger L, Humphrey J, Sukasih A, Bluthenthal R, et al.
Drug Alcohol Depend Rep
. 2025 Jan;
14:100317.
PMID: 39877805
Background: In response to the recent and growing shift from injecting heroin to smoking fentanyl, an increasing number of syringe services programs (SSPs) in the United States are distributing safer...
6.
Humphrey J, Schwab C, Richardson N, Lambdin B, Kral A, Ray B
J Epidemiol Community Health
. 2024 Oct;
79(2):147-152.
PMID: 39389758
Background: The opioid overdose mortality crisis in the USA is an ongoing public health epidemic. Ongoing law enforcement strategies to disrupt local unregulated drug markets can have an iatrogenic effect...
7.
Smiley-McDonald H, Chung E, Wenger L, Godvin M, Good D, Leichtling G, et al.
Drug Alcohol Depend
. 2024 Sep;
264:112449.
PMID: 39326277
Background: In February 2021, Measure 110 (M110) in Oregon decriminalized noncommercial possession of drugs. We examined criminal legal system (CLS) involvement of people who use drugs (PWUD) 2 years after...
8.
Zoorob M, Park J, Kral A, Lambdin B, Del Pozo B
JAMA Netw Open
. 2024 Sep;
7(9):e2431612.
PMID: 39235814
Importance: With the implementation of Measure 110 (M110) in 2021, Oregon became the first US state to decriminalize small amounts of any drug for personal use. To date, no analysis...
9.
Akiba C, Smith J, Wenger L, Morris T, Patel S, Bluthenthal R, et al.
SSM Qual Res Health
. 2024 Jul;
5.
PMID: 38957482
Syringe Services Programs (SSPs) provide evidence-based services like drug use equipment to prevent infectious disease, overdose prevention education, and naloxone distribution to people who use drugs (PWUD). However, inadequate funding...
10.
Ray B, Humphrey J, Patel S, Akiba C, Bluthenthal R, Tookes H, et al.
Lancet Reg Health Am
. 2024 May;
34:100757.
PMID: 38745887
Background: Syringe services programmes (SSPs) are an evidence-based strategy to reduce infectious diseases and deliver overdose prevention interventions for people who use drugs. They face regulatory, administrative, and funding barriers...